Share on LinkedInShare on LinkedIn

ARTICLE · 09 JUNE 2021

US Announces Support For Waiver Of Intellectual Property Rights

Marks & Clerk
Marks & Clerk
Contributor
Marks & Clerk

Marks & Clerk

Marks & Clerk LLP was founded in 1887 by George Croydon Marks, who was joined in partnership by...

View firm profile
Explore more from Marks & Clerk

In an unexpected move last week, the Office of the United States Trade Representative (on behalf of the Biden-Harris Administration)

GlobalIntellectual Property

In an unexpected move last week, the Office of the United States Trade Representative (on behalf of the Biden-Harris Administration) announced its support for a waiver of intellectual property protections afforded by the TRIPS Agreement for Covid-19 vaccines.

The announcement represents a shift in position by the US which (along with the EU, UK, Japan, Switzerland, Brazil and Norway) resisted a similar proposal submitted by India and South Africa in October 2020.

A waiver of patent protection for Covid-19 treatments is supported by India, South Africa and 57 other World Trade Organisation Members. Further, both Labour and the Liberal Democrats have urged the UK government to support a waiver. The UK is yet to formally announce its position.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from